Brief: NeuroVive Jan-March Loss Before Tax Widens To SEK 13.8 Million

Abliva AB

21/05/2019 07:45

May 21 (Reuters) - NeuroVive Pharmaceutical AB  NVP.ST :
    * INTERIM REPORT JANUARY - MARCH 2019
    * JAN-MARCH  LOSS BEFORE TAX: KSEK -13,822 (-13,053)

Source text for Eikon:  ID:nWkr8gS6GX 
Further company coverage:  NVP.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))